SpringWorks Therapeutics Eulerpool News

SpringWorks Therapeutics Eulerpool News

SpringWorks Therapeutics Stock News

SpringWorks Therapeutics is being monitored by journalists and investors worldwide. We gather the latest SpringWorks Therapeutics news here.

• September 5 ·

  Yahoo
  SpringWorks Therapeutics Inc (SWTX) CEO Saqib Islam Sells 49,000 Shares
• September 4 ·

  TipRanks
  Springworks Therapeutics: Promising Outlook for Ogsiveo Drives Overweight Rating and Elevated Price Target
• September 4 ·

  Thefly.com
  SpringWorks Therapeutics price target raised by $4 at JPMorgan, here's why
• August 29 ·

  SeekingAlpha
  Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2024 Update
• August 28 ·

  Seeking Alpha
  FDA accepts SpringWorks' application for mirdametinib for NF1-PN
• August 28 ·

  Yahoo
  FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
• August 28 ·

  Seeking Alpha
  FDA accepts SpringWorks application for mirdametinib for NF1-PN
• August 28 ·

  TipRanks
  Buy Rating Affirmed for Springworks Therapeutics on Strong Outlook for Mirdametinib
• August 28 ·

  GlobeNewswire
  FDA Grants Priority Review to SpringWorks Therapeutics? New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
• August 28 ·

  Thefly.com
  SpringWorks Therapeutics: FDA grants priority review to NDA for mirdametinib